By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    A Shanghai lab turns its whole bench over to AI agents
    By
    msadmin
    November 5, 2026
    Britain’s Sovereign AI bets seed money on physics instead of wet labs
    By
    msadmin
    November 5, 2026
    AI measures heart function more consistently than expert readers
    By
    msadmin
    November 5, 2026
    AstraZeneca tests AI on the tissue slides that decide drug safety
    By
    msadmin
    November 5, 2026
    Evident Vascular clears FDA hurdle with a fully AI native IVUS console
    By
    msadmin
    November 5, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Singapore clinics let an AI watch for referrals nobody ever sent
    By
    msadmin
    November 1, 2026
    An AI team of agents grades immunotherapy side effects
    By
    msadmin
    October 30, 2026
    Brain implant decoders fail when patients or hardware change, review warns
    By
    msadmin
    October 25, 2026
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

Medtronic wins FDA nod to bring LigaSure onto the Hugo robot

The clearance puts Medtronic's vessel-sealing technology, used in 45 million procedures, onto its own robotic surgery platform.

MedSpark Staff
By
msadmin
MedSpark Staff
Bymsadmin
Medical, Healthcare, & Biotech/Pharma AI News
Follow:
Published: September 20, 2026
Share
1 Min Read
SHARE

A vessel-sealing tool Medtronic already sells for open and laparoscopic work is now cleared for use on the company’s own surgical robot. Regulators granted the clearance for LigaSure aboard Hugo, Medtronic’s soft tissue robotic system.

LigaSure ranks among Medtronic’s most widely used instruments, with a track record spanning tens of millions of procedures. The clearance, disclosed Wednesday, pushes the instrument line onto the robotic platform and gives surgical teams energy tools they already know.

Medtronic filed its 510(k) paperwork in June. That request was one of several meant to grow the instrument catalogue for Hugo and widen the robot’s approved indications.

Intuitive Surgical dominates robotic surgery, and Medtronic wants share. Rather than ask hospitals to adopt an unfamiliar toolkit, the company pairs Hugo with energy instruments physicians already handle in non-robotic cases.

The clearance broadens the competitive field beyond hardware alone. Instrument breadth and clinical familiarity are increasingly deciding factors as more vendors field soft tissue robots.

TAGGED:FDA clearanceHugo systemLigaSureMedical DevicesMedtronicrobotic surgerySurgical robots
SOURCES:MedTech DiveUnite.AI
Share This Article
Facebook Copy Link Print
MedSpark Staff
Bymsadmin
Follow:
Medical, Healthcare, & Biotech/Pharma AI News

You Might Also Like

News & Alerts

Agentic AI roadmap aims to bring dementia expertise into primary care

By
msadmin
August 2, 2026
News & Alerts

Gates and Bezos back LifeMine’s $188M fungal drug revival

By
msadmin
August 9, 2026
News & Alerts

Treso banks $3.75M to straighten out a clinic’s books

By
msadmin
October 17, 2026
News & Alerts

Pythia Labs emerges with an AI model that writes working antibodies

By
msadmin
October 27, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal